Less optimized therapeutic effects constrain the use of doxorubicin as the main agent of chemotherapy for metastatic breast cancer, resistance and side effects. Therefore we need a combination of more than one chemopreventive agent which has different molecular targets to solve that problem. The aims of this study is to prove the inhibitory effect of ethanolic extract of rhizome of Curcuma xanthorrhiza (ECx), fruit of Brucea javanica (EBj), leave of Ficus septica (EFs) and doxorubicin (Dox) alone and its combination on migration and invasion of a highly metastatic 4T1 breast cancer cell line. Cytotoxic activity of single and combination treatment was evaluated by MTT assay, followed by an experiment of apoptosis induction by using flow cytometry. The inhibitory effect on migration was observed by the scratch wound-healing assay. Furthermore, the observation of the activity of matrix metalloproteinase-9 (MMP-9) was analyzed by gelatin zymography. The results showed that ECx, EBj, EFs, and Dox has cytotoxic activity on 4T1 cells with the value of IC50 respectively 49.7±1.53g/mL, 59.9±1.79g/mL, 15.2±2.12g/mL and 1.2±0.23M. Furthermore, the combination of ECx-EBj-Dox and ECx-EBj-EFs revealed a synergistic effect on 4T1 cells and decrease cell viability through the induction of apoptosis and necrosis. Based on wound healing assay, 24h incubation of this combination inhibited 4T1 cells migration compared to single treatment. Gelatin zymography analysis showed that this combination also inhibited the activity of MMP-9 greater than a single use. Curcuma xanthorrhiza, Brucea javanica, and Ficus septica may have potential to be developed as a combination with or without doxorubicin for metastatic breast cancer treatment.
INTRODUCTION
Breast cancer is the first leading cause of cancer deaths in women. Doxorubicin is an important modality for the treatment of breast cancer metastasis in addition to surgery (Bapsy and Sahoo, 2006) . Long term use of doxorubicin causes several side effects, resistance and toxicity to normal tissues (Smith et al., 2010) . Therefore, combining doxorubicin with the chemopreventive agent is needed to increase the activity of doxorubicin, to overcome the drug resistance and to reduce its side effect (Sarkar and Li, 2006) .
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The chemopreventive agent used in this research is a combination of Brucea javanica (EBj), Ficus septica (EFs) and Curcuma xanthorrhiza (ECx) . Many clinical studies have suggested that Brucea javanica can be used alone as a conventional treatment for various cancers.
However, the present study shows that Brucea javanica has synergistic effects when combined with certain anticancer drugs or radiotherapy (Nie et al., 2012) . The leaves of Ficus septica have been used to treat various cancers. The ethanolic extract of Ficus septica showed a cytotoxic effect on breast cancer T47D cell lines with an IC50 value of 13µg/mL. The extract at 4.88µg/mL also showed an optimum synergistic effect in combination with doxorubicin (3.75nM) (Pratama et al., 2010) . Besides, the extract induced apoptosis and downregulated the expression of Bcl-2 protein in breast cancer cells MCF-7 (Sekti et al., 2010) . The principal components of Curcuma xanthorrhiza are curcumin and xanthorrhizol. Curcumin suppresses many key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation (Kunumakkara et al., 2008) . Choi et al. (2005) observed that injection of 0.2-1.0mg/kg BW xanthorrhizol had an antimetastatic effect in a mouse lung metastasis model.
There have been several reports about the combination of doxorubicin with one kind of chemopreventive agent, and its synergistic has been proved (Lewandowska et al., 2014) , but study using a combination of more than one kind of chemopreventive agents with doxorubicin has not been done, mainly to prove its effectiveness as an antimetastasis agent in advanced breast cancer. This research combined ECx, and EBj with Dox to increase effectivity, to overcome drug resistance, and to reduce its side effect while the combination of three chemopreventive agents (ECx, EFs and EBj) without chemotherapy Dox is assumed to get nontoxic nature of EFs and to eliminate the side effect of Dox. 
MATERIAL AND METHODS

Cytotoxicity assay
Various concentrations of samples (ECx, EBj, EFs, Dox, and its combination), DMEM culture medium (Gibco) with 10% FBS, 1% penicillinstreptomycin and fungizone were used to conduct the cytotoxic colorimetric MTT assay on 4T1 breast cancer cells. It was used to determine the IC50 value. Afterwards, a cytotoxicity assay was also conducted to determine the effect of the combination of various sample concentrations treatment (Mosmann, 1983) .
Flow cytometric apoptosis assay
Cells were added with Annexin-V-FLUOS Staining Kit (Roche) consisting of 200µL of binding buffer, 2µL of Annexin V, 2µL propidium iodide (PI) and incubated for 10min in the dark room according to manufacturer's instruction, then transferred into a flow cytometry tube and analyzed by flow cytometer (BD FACS Calibur, BD Bioscience) (Engeland et al., 1998) .
Scratch wound healing assay
The 4T1 cells (7.5x10 4 ) were cultured in 24-well plate and incubated for 24h. After starvation, cells were scratched by using sterile yellow tip then treated with various concentrations of samples. The cells were documented at 0, 18, and 24h (Liang et al., 2007) . The results were analyzed by using ImageJ software and converted to percentage closure parameter.
Gelatin zymography
The SDS-PAGE 8% supplemented with 0.1% gelatin was used to determine the activity of MMP-9 in the culture medium. After electro-phoresis running, gels were washed and incubated at room temperature. The reaction buffer was added and incubated for 24h at 37°C. Gels were stained by using Coomassie Brilliant Blue R-250 (Sigma) and 17 destained until clear bands with dark blue background appeared (Kupai, 2011) . The results were documented and analyzed by using Image J software.
Statistical analysis
Oneway ANOVA followed by the least significant difference (LSD) were used to assess the statistical significance. A statistically significant difference was considered to be present at p<0.05. The results of scratch wound healing assay and gelatine zymography were documented and analyzed using Image J software before ANOVA.
Combination cytotoxicity assay and synergicity
The effect of combination treatment on 4T1 cells was evaluated by calculating the Combination Index (CI) value using the formula. Interpretation of the data was based on the classification (Reynolds and Maurer, 2005) .
RESULTS AND DISCUSSION
Effects of ECx, EBj, EFs, Dox alone and its combination on cell viability of 4T1
A single treatment of ECx, EBj, EFs, or Dox showed cytotoxic effect on 4Tl breast cancer cells with IC50 value respectively 49.7±1.53g/mL, 59.9±1.79g/mL, 15.2±2.12g/mL and 1.2±0.23M (Figure 1) . The reduction of cell viability of combination of ECx-EBj-EFs and ECx-EBj-Dox is greater than the single treatment. The combination of ECx-EBj-Dox using concentrations of ½ IC50 showed synergistic effects with a CI value of 0.63 and reduced cell viability up to 65% (Sutejo, 2015) . The combination of ECx-EBj-EFs using concentrations of ½ IC50 showed synergistic effects with a CI value of 0.83 and reduced cell viability up to 63% (Figure 2 ).
The combination of ECx-EBj-EFs and ECx-EBjDox increase apoptosis and necrosis on 4T1 cells
The observation of apoptosis was done by using concentration ⅓IC50 of each agent. All single treatments and combination induced apoptosis on 4T1. The percentage of living cells in control was 92.18%, while the percentage of apoptotic cells is 6.34% and necrotic cells were 2.17%. After a single treatment ECx, EBj, EFs, and Dox, the percentages of cells undergoing apoptosis were respectively 12.08%, 6.22%, 10.47% and 13.41%. The treatment with ECx-EBj-EFs and ECx-EBj-Dox for 24h incubation increased the apoptotic cells by 14.46% and 11.99% (Figure 3) .
The combination of ECx-EBj-EFs and ECx-EBjDox inhibit migration of 4T1 cells
The observation of cell migration activity was done by using concentration ¼ IC50 of each agent. The effect on cell migration was observed at time point 0, 18, and 24h. The single treatment of ECx, EBj, EFs, Dox and its combination decrease cell migration of 4T1. The ability of the most robust inhibition to the lowest showed by the combination of ECx-EBj-EFs, ECx-EBj-Dox, and then ECx, EFs, followed by EBj, and the least one was doxorubicin (Figure 4) .
The combination of ECx-EBj-EFs and ECxEBj-Dox inhibit activity of MMP-9 on 4T1 cells
The treatment was done by using concentration ¼ IC50 of each agent. The single treatment of ECx, EFs, and EBj is more potential to inhibit the activity of MMP-9 than doxorubicin. The combination of ECx-EBj-EFs and ECx-EBj-Dox resulted in much greater inhibition of MMP-9 activity than a single treatment ( Figure 5 ).
Discussion
The single treatment of ECx, EBj, EFs, and Dox was proven to have a cytotoxic effect on 4T1 cells (Figure 1) , and its combination showed a synergism to reduce cell viability greater than a single treatment (Figure 2 ). It was supported by the previous study statements that each Curcuma xanthorrhiza, Brucea javanica, and Ficus septica increased the effects of chemotherapy (Kunnumakkara et al., 2008) . Combination of ECxEBj-EFs was as potent as ECx-EBj-Dox to induce 4T1 cells death (Figure 3 ). Mechanism of cell growth inhibition both two combinations was due to apoptosis and necrosis pathways. The molecular mechanisms underlined the apoptosis after treatment of ECx, EBj and EFs in 4T1 cells was through p53-independent pathways, due to 4T1 breast cancer cells line characteristic which is lack of protein p53 expression (Tao et al., 2008) . Whereas doxorubicin induces necrosis through increased TNFα and ROS (Sugimoto et al., 2002) .
The rhizomes of Curcuma xanthorrhiza contains volatile oil, saponin, flavonoid, and tannin. Chemistry analysis showed that the main substances of Curcuma xanthorrhiza are curcumin, desmethoxycurcumin and xanthorrhizol (Choi et al., 2005) . Most of the studies on Ficus septica leaves reported on the phenanthroindolizidine alkaloid which has a cytotoxic effect on cancer cells (Sekti et al., 2010) .
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Volume 30 Issue 1 (2019) Figure 1 . Cytotoxic effect of single treatment of ECx, EBj, EFs, and Dox on 4T1 Cells. 5x10 3 cells/well were seeded in 96 well plate and incubated for 24h, then treated with ECx, EBj, EFs and Dox. Cell viability was determined by using MTT assay as described in the method. Morphology cells after a single treatment of ECx, EBj, EFs (A) or Dox (B) for 24h. Arrows indicate cell morphological changes. Cell viability profile after a single treatment of ECx, EBj, EFs (C) or Dox (D) for 24h. Profile of cell viability were means ± SD from 3 independent experiments. Several natural components from Brucea javanica fruit include the tetracyclic triterpene quassinoids, anthraquinone, olein, oleic acid, linoleic acid, pregnane glucosides, and sesquiterpenes. In particular, tetracyclic triterpene quassinoids (brucein A and bruceantin) are the main active ingredients of Brucea javanica with remarkable antitumor activity (Chen et al., 2013) .
The treatment of ECx, EBj, EFs, and Dox alone or in combination inhibited the migration of 4T1 breast cancer cells (Figure 4) . The interesting finding was that Dox as the main chemotherapy in advanced cancer has the lowest antimigration activity compared to ECx, EBj and EFs (Figure 4) . Bandyopadhyay et al. (2010) and Krstic and Santibanez (2014) proved that doxorubicin increases migration and invasion of 4T1 and MDAMB-231cells through induction of TGFβ. Those findings in line with our result that the combination of ECx-EBj-EFs inhibited cells migration greater than ECxEBj-Dox. Metastasis inhibition of doxorubicin which was seen in this study was due to cell death caused by doxorubicin treatment. Although the mechanism is not clear, single doxorubicin proved to inhibit the M5076 ovarian cancer cell metastasis in vivo (Sugiyama and Sadzuka, 1999) . Several reports related to the antimetastasis potency of the active compounds contained in the extracts we used are as follows. Curcumin as the main active ingredient of ECx, inhibit the migration of breast cancer cells MDAMB-231 by suppressing the FAK pathway and lowering the expression of PI3K and were subsequently able to decrease the expression of VEGF (Lin et al., 2009) . Curcumin also inhibits the expression of MMP-9 causing a decrease of MMP-9 activity, inhibits β-catenin and reduce the loss of E-cadherin, which is related to the ability of invasion and metastasis of cancer cells (Thangapazham et al., 2006) . Alkaloids phenanthroindolizidine from Ficus septica inhibits expression of COX-2 proteins (Mandhare et al., 2015) . 
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Brucein A and bruceantin are known to inhibit the invasion and migration of tumour cells targeting at MRP-1/CD9 and integrinα-5 (Nan et al., 2015) . Brucein A from Brucea javanica lowered VEGF expression so that no signal is transmitted through the VEGF receptor (Xinjie and Linyi, 2013) . Moreover, Brucea javanica and Ficus septica also suppress the activation of NF-кB and inhibits expression of COX-2 proteins that promote invasion (Kim et al., 2010; Mandhare et al., 2015) . The mechanisms above explain our findings that the combination of ECx-EBj-EFs and ECx-EBj-Dox inhibited cells migration greater than the single treatment ( Figure 4B ). The fact that Dox has not only induced cell migration but also cell invasion also explains our data that the combination of ECx-EBj-EFs inhibited MMP-9 activity greater than ECx-EBj-Dox ( Figure  5B ).
CONCLUSION
The results of this study conclude that both two combinations of ECx-EBj-Dox and ECx-EBj-EFs have a cytotoxic effect via apoptosis and necrosis pathways. The combination of ECx-EBj-EFs has antimigration activity and inhibition of cancer cell invasion greater than ECx-EBj-Dox. Both two combinations have a potency to be developed as a co-chemotherapy agent in breast cancer metastasis. Nevertheless, further researches are still needed in order to apply such combination therapy for cancer patients. 
